HPV in females is caused by infection with the human papillomavirus, a group of more than 200 related viruses spread primarily through sexual contact. About 40% of women ages 18 to 59 carry at least one genital HPV type at any given time, making it the most common sexually transmitted infection in the United States. The virus passes through skin-to-skin contact during vaginal sex, anal sex, or other intimate genital touching, and most sexually active women will encounter it at some point in their lives.
How HPV Spreads to Women
HPV transmits through direct skin-to-skin contact, not through blood or bodily fluids. Vaginal and anal sex are the most common routes, but the virus can also spread through close genital touching without penetration. Condoms reduce the risk but don’t eliminate it entirely because HPV can live on skin that a condom doesn’t cover.
At a biological level, the virus needs access to the deepest layer of skin cells. It enters through tiny breaks or micro-abrasions in the skin or mucosal lining of the cervix, vagina, or vulva. Once exposed, the virus attaches to proteins on the basement membrane (the foundation layer beneath your skin cells) and undergoes a shape change that allows it to latch onto cells migrating into the area of the wound. This is why even minor friction during sexual contact can be enough for the virus to establish an infection.
Why Most Women Never Know They Have It
High-risk HPV types produce no symptoms at all. There are no bumps, no pain, no unusual discharge. The infection sits quietly in the cells of the cervix or other tissue, and the only way to detect it is through screening tests like a Pap smear or HPV test. This is a key reason HPV spreads so easily: partners can pass the virus without either person realizing it’s there.
Low-risk HPV types sometimes cause visible genital warts, which can appear weeks or months after exposure. But even low-risk infections often remain invisible. The gap between exposure and any detectable change in cells can stretch from months to years, making it nearly impossible to pinpoint exactly when or from whom someone contracted the virus.
High-Risk vs. Low-Risk Types
Not all HPV types are equally dangerous. Scientists classify sexually transmitted HPV into two categories based on their potential to cause cancer.
There are 12 high-risk types: HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59. Of these, HPV 16 and 18 are responsible for the majority of HPV-related cancers. In women, persistent high-risk infections can lead to cervical cancer, vaginal cancer, vulvar cancer, anal cancer, and oropharyngeal (throat) cancer. These cancers develop slowly, typically over many years or even decades of ongoing infection.
Low-risk types rarely cause cancer. Their main consequence is genital warts or, less commonly, warts in the throat or respiratory tract. While uncomfortable and sometimes distressing, low-risk infections are not considered a cancer threat.
What Makes Some Infections Persist
For 90% of women with HPV, the immune system clears the virus on its own within two years. The infection simply disappears without treatment. The remaining 10% develop persistent infections, and it’s these long-lasting infections that carry the real health risks.
Several factors make it harder for your body to fight off the virus:
- Weakened immune system: Women living with HIV, those taking immunosuppressive medications after an organ transplant, or those being treated for autoimmune conditions are significantly more likely to develop persistent HPV infections that progress toward cancer.
- Smoking: Tobacco use impairs the immune response in cervical tissue specifically, making it harder for the body to clear HPV from that area.
- Multiple HPV types: Being infected with more than one strain at the same time can complicate the immune response.
When a high-risk HPV infection persists for years, it can gradually change the infected cells into precancerous cells. Without screening and treatment, those precancerous cells can eventually become cancer. This progression typically takes 10 to 20 years, which is why regular cervical screening catches the vast majority of problems long before cancer develops.
Can HPV Spread Without Sex?
While sexual contact is overwhelmingly the primary route, HPV can also pass from mother to child during childbirth. A meta-analysis of over 3,000 mother-child pairs found that children born to HPV-positive mothers were 33% more likely to test positive for HPV than those born to HPV-negative mothers. In one study, nearly 23% of oral samples taken from newborns immediately after birth tested positive for HPV DNA.
This type of transmission appears to be mostly temporary. In follow-up studies, HPV positivity disappeared within days in about 38% of newborns who initially tested positive. In rare cases, perinatal transmission can lead to a condition called respiratory papillomatosis, where warts grow in the child’s airway, but this remains uncommon.
How Vaccination Changes the Picture
The HPV vaccine is the most effective way to prevent infection before it happens. It protects against the high-risk types most likely to cause cancer and the low-risk types responsible for genital warts. The CDC recommends vaccination for children at age 11 or 12, though it can be started as early as age 9 and is recommended through age 26 for anyone who wasn’t vaccinated earlier. Adults ages 27 through 45 who missed vaccination may still benefit and can discuss it with a healthcare provider.
More than 15 years of real-world data show the vaccine provides safe, effective, and long-lasting protection against HPV-related cancers. For women who are already sexually active, the vaccine still offers protection against HPV types they haven’t yet encountered, though it cannot clear an existing infection. Routine cervical screening remains important regardless of vaccination status, since the vaccine doesn’t cover every high-risk type.
Why HPV Is So Common in Women
The combination of factors working in HPV’s favor is unusual among infections. The virus is incredibly stable on skin, requires only skin contact to transmit, produces no symptoms in most carriers, and can linger for months before the immune system mounts a response. At any given time, about 20% of women carry a high-risk genital HPV type, and the real cumulative lifetime exposure rate is far higher since most infections clear and aren’t captured in one-time surveys.
The cervix is particularly vulnerable because it contains a transition zone where two types of cells meet. This area undergoes frequent cell turnover, especially in younger women, creating natural opportunities for the virus to access the deeper cell layers it needs to infect. This biological reality, combined with the virus’s stealth, explains why HPV remains so widespread even in populations with good access to healthcare.